Positioning Providers to Take on Risk
As the market moves rapidly toward value-based care, one physician describes how working with New Century Health gave his practice the confidence and support to succeed in an advanced alternative payment model.
Other content in this Stream
Evolent Health, Parent Company of New Century Health, Names Kim Keck To Board of Directors
Evolent Health, Parent Company of New Century Health, Names Kim Keck to Board of Directors. Announces Cheryl Scott to Serve as Lead Independent Director.
Pathways, Portals and Persuasion: Reining in an Overused Cancer Agent
NCH's approach to more appropriate use of myeloid growth factor provides a playbook for how to change prescribing patterns.
New Century Health recently convened health plan executives, industry experts and oncologists from across the nation to discuss the confluence of forces shaping oncology care in 2021 and beyond.
New Century Health to Support Florida Blue Medicare with Comprehensive Oncology Management Services
The company will leverage New Century Health’s oncology specialty management program to help ensure its more than 125,000 Medicare Advantage members receive high-quality cancer care.
New Century Health’s John Davis hosts a virtual “fireside chat” with Dr. Elizabeth Malko, Dr. Vinay Prasad, and Dr. Andrew Hertler.
Key Forces Impacting Cancer Care: An Interview with Dr. Vinay Prasad
New Century Health's John Davis recently sat down with Dr. Prasad, author of "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer," to discuss key forces impacting cancer care.
How Real-World Evidence Can Transform High-Value Oncology Pathways
Our CMO Dr. Andrew Hertler explains how real world evidence may usher in the next generation of clinical oncology pathways.
Recent journal article details how NCH and Cancer Care Specialists of Illinois teamed up to slow growth in drug spend.
New Century Health Achieves NCQA Accreditation in Utilization Management
NCH also recertified by HITRUST® for patient privacy and data security protection.
Driving Culture Change in the Pursuit of Value: A Q&A with Cancer Care Specialists of Illinois
Dr. Mark Walshauser describes the impact of high-value oncology pathways and peer collaboration on his community practice.
Increasing use of real-world evidence is one of the most exciting trends in pathway development, our CMO tells Journal of Clinical Pathways.
Medscape delves into our work with a community oncology practice to implement high-value clinical pathways and engage providers
Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and impact of COVID-19.
Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?
The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.
Cancer Care Specialists of Illinois reduced drug spend by 13.5% compared to peer practices by deploying our care pathway and physician collaboration protocols
On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care
Watch this on-demand webinar to explore the future of cancer care in a post COVID-19 world.
Our chief medical officer, Dr. Andrew Hertler, speaks with Journal of Clinical Pathways about our approach to high-value cancer care.
Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.
Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.